Phenominer Database Results (6 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Site Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Clinical Measurement Notes Record ID Study ID
DA.ACI-(D10Rat219-D10Rat29) experimental autoimmune encephalomyelitis duration myelin oligodendrocyte glycoprotein (200 ul) Jagodic M, et al., J Immunol 2004 Jul 15;173(2):1366-73. central nervous system integrity trait not specified 63.0 days-105.0 days 13 7.4 d 1.2 4.33 in vivo visual assessment whole animal 0.0 injection 40 days range 31 to 40 days 68230 829
DA.ACI-(D10Rat219-D10Rat29) percentage of study population developing experimental autoimmune encephalomyelitis during a period of time myelin oligodendrocyte glycoprotein (200 ul) Jagodic M, et al., J Immunol 2004 Jul 15;173(2):1366-73. central nervous system integrity trait not specified 63.0 days-105.0 days 16 81.2 % in vivo visual assessment whole animal 0.0 injection 40 days range 31 to 40 days 67874 829
DA.ACI-(D10Rat219-D10Rat29) experimental autoimmune encephalomyelitis duration myelin oligodendrocyte glycoprotein (200 ul) Jagodic M, et al., J Immunol 2004 Jul 15;173(2):1366-73. central nervous system integrity trait not specified 63.0 days-105.0 days 6 11.5 d 2.6 6.37 in vivo visual assessment whole animal 0.0 injection 40 days range 31 to 40 days 68215 829
DA.ACI-(D10Rat219-D10Rat29) percentage of study population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of time myelin oligodendrocyte glycoprotein (200 ul) Jagodic M, et al., J Immunol 2004 Jul 15;173(2):1366-73. central nervous system integrity trait not specified 63.0 days-105.0 days 10 40.0 % in vivo visual assessment whole animal 0.0 injection 40 days range 31 to 40 days 68216 829
DA.ACI-(D10Rat219-D10Rat29) percentage of study population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of time myelin oligodendrocyte glycoprotein (200 ul) Jagodic M, et al., J Immunol 2004 Jul 15;173(2):1366-73. central nervous system integrity trait not specified 63.0 days-105.0 days 16 25.0 % in vivo visual assessment whole animal 0.0 injection 40 days range 31 to 40 days expressed as a fraction of total number of animals 68231 829
DA.ACI-(D10Rat219-D10Rat29) percentage of study population developing experimental autoimmune encephalomyelitis during a period of time myelin oligodendrocyte glycoprotein (200 ul) Jagodic M, et al., J Immunol 2004 Jul 15;173(2):1366-73. central nervous system integrity trait not specified 63.0 days-105.0 days 10 60.0 % in vivo visual assessment whole animal 0.0 injection 40 days range 31 to 40 days 67873 829